Jurgen Passage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jurgen Passage has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Pragnesh Joshi
Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Perth, WA, Australia; School of Medicine, The University of Notre Dame, Fremantle, WA, Australia; The Baird Institute, Sydney, NSW, Australia
3 shared publications- Andrew Hugh Ford
Medical School, University of Western Australia, Perth, Australia (O.P.A., A.H.F., C.E.B., L.F., G.J.H.).
1 shared publication B. Murphy
Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Perth, WA, Australia
1 shared publication- Bradley Wibrow
Sir Charles Gairdner Hospital
1 shared publication Chaitanya Tak
Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Western Australia
1 shared publicationCharles Jenkinson
Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Hospital Avenue, Perth, Western Australia, Australia
1 shared publication
Latest Publications
- 1 January 2018
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 27, S584-S585
Sternotomy: Reduced Pain With ‘Self-hug’
- 1 January 2018
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 27, S584-S585
Sternotomy: Reduced Pain With ‘Self-hug’
- 1 November 2017
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 26 (11) , e82-e85
Acute Structural Failure of the Trifecta Aortic Valve Bioprosthesis
- 1 November 2017
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 26 (11) , e82-e85
Acute Structural Failure of the Trifecta Aortic Valve Bioprosthesis
- 1 December 2016
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25 (12) , 1240-1244
Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive Cases
- 1 December 2016
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25 (12) , 1240-1244
Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive Cases
- Open Access
- 1 May 2016
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 11 (3) , 219-221
Modified Valsalva Maneuver for Venous Cannulation in Cardiopulmonary Bypass for Minimal Incision Mitral Valve Surgery
A 69-year-old man underwent minimal incision mitral valve repair for severe symptomatic mitral regurgitation. The echocardiography showed that he had normal left ventricular function with a moderately to severely dilated left atrium, a mildly dilated right atrium, and a large patent foramen ovale. The multistage venous cannulation was very challenging because we could not negotiate the guide wire from the inferior vena cava via the right atrium into the superior vena cava. Despite several attempts, the guide wire would pass into the patent foramen ovale. Methods that we routinely attempt with difficult cannulations such as withdrawing and reinserting, twisting, and to-and-fro movements did not result in success. Eventually, we attempted a novel maneuver, the modified “Valsalva maneuver,” that worked incredibly well.
- 1 May 2016
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 11 (3) , 219-221
Open AccessModified Valsalva Maneuver for Venous Cannulation in Cardiopulmonary Bypass for Minimal Incision Mitral Valve Surgery
A 69-year-old man underwent minimal incision mitral valve repair for severe symptomatic mitral regurgitation. The echocardiography showed that he had normal left ventricular function with a moderately to severely dilated left atrium, a mildly dilated right atrium, and a large patent foramen ovale. The multistage venous cannulation was very challenging because we could not negotiate the guide wire from the inferior vena cava via the right atrium into the superior vena cava. Despite several attempts, the guide wire would pass into the patent foramen ovale. Methods that we routinely attempt with difficult cannulations such as withdrawing and reinserting, twisting, and to-and-fro movements did not result in success. Eventually, we attempted a novel maneuver, the modified “Valsalva maneuver,” that worked incredibly well.
- Open Access
- 28 January 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 1-8
The Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial
Delirium is a common occurrence in patients undergoing major cardiac surgery and is associated with a number of adverse consequences for the individual, their family and the health system. Current approaches to the prevention of delirium include identifying those at risk together with various non-pharmacological and pharmacological strategies, although the efficacy of these is often modest. Emerging evidence suggests that melatonin may be biologically implicated in the development of delirium and that melatonin supplementation may be beneficial in reducing the incidence of delirium in medical and surgical patients. We designed this trial to determine whether melatonin reduces the incidence of delirium following cardiac surgery compared with placebo. The Healthy Heart-Mind trial is a randomized, double-blind, placebo-controlled clinical trial of 3 mg melatonin or matching placebo administered on seven consecutive days for the prevention of delirium following cardiac surgery. We will recruit 210 adult participants, aged 50 and older, undergoing elective or semi-elective cardiac surgery with the primary outcome of interest for this study being the difference in the incidence of delirium between the groups within 7 days of surgery. Secondary outcomes of interest include the difference between groups in the severity and duration of delirious episodes, hospital length of stay and referrals to mental health services during admission. In addition, we will assess differences in depressive and anxiety symptoms, as well as cognitive performance, at discharge and 3 months after surgery. The results of this trial will clarify whether melatonin reduces the incidence of delirium following cardiac surgery. The trial is registered with the Australian Clinical Trials Registry, trial number ACTRN12615000819527 (10 August 2015).
- 28 January 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 1-8
Open AccessThe Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial
Delirium is a common occurrence in patients undergoing major cardiac surgery and is associated with a number of adverse consequences for the individual, their family and the health system. Current approaches to the prevention of delirium include identifying those at risk together with various non-pharmacological and pharmacological strategies, although the efficacy of these is often modest. Emerging evidence suggests that melatonin may be biologically implicated in the development of delirium and that melatonin supplementation may be beneficial in reducing the incidence of delirium in medical and surgical patients. We designed this trial to determine whether melatonin reduces the incidence of delirium following cardiac surgery compared with placebo. The Healthy Heart-Mind trial is a randomized, double-blind, placebo-controlled clinical trial of 3 mg melatonin or matching placebo administered on seven consecutive days for the prevention of delirium following cardiac surgery. We will recruit 210 adult participants, aged 50 and older, undergoing elective or semi-elective cardiac surgery with the primary outcome of interest for this study being the difference in the incidence of delirium between the groups within 7 days of surgery. Secondary outcomes of interest include the difference between groups in the severity and duration of delirious episodes, hospital length of stay and referrals to mental health services during admission. In addition, we will assess differences in depressive and anxiety symptoms, as well as cognitive performance, at discharge and 3 months after surgery. The results of this trial will clarify whether melatonin reduces the incidence of delirium following cardiac surgery. The trial is registered with the Australian Clinical Trials Registry, trial number ACTRN12615000819527 (10 August 2015).
- 1 January 2014
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 23 (1) , e8-e9
Refractory Ascites – A Rare Presentation of Severe Aortic Regurgitation
- 1 January 2014
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 23 (1) , e8-e9
Refractory Ascites – A Rare Presentation of Severe Aortic Regurgitation
- 1 September 2013
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 22 (9) , 772-774
Right Ventricular Perforation during Femoral Venous Cannulation – Lessons Learned
- 1 September 2013
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 22 (9) , 772-774
Right Ventricular Perforation during Femoral Venous Cannulation – Lessons Learned